(Q30532494)

English

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Robert L Vessella

10

object named as

Robert L Vessella

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Celestia Higano

9

object named as

Celestia S Higano

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Lawrence D True

4

object named as

Lawrence D True

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Colm Morrissey

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Martine P Roudier

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Alex Dowell

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Melanie Ketchanji

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Christopher Welty

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Eva Corey

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Paul H Lange

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

1 February 2013

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

28

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

333-340

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Giant osteoclast formation and long-term oral bisphosphonate therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Histopathological assessment of prostate cancer bone osteoblastic metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Clinical features of metastatic bone disease and risk of skeletal morbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Cellular and molecular mechanisms of action of bisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Pain management in patients with advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

20 June 2018

Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1749

21 January 2018

Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547166

26 November 2018

Histochemistry and immunohistochemistry on bone marrow biopsies. A rapid procedure for methyl methacrylate embedding

1 reference

https://pubmed.ncbi.nlm.nih.gov/22936276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22936276

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JBMR.1749

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30532494&oldid=2186412373"